Cel-Sci
CVM
#10549
Rank
A$29.53 M
Marketcap
A$1.69
Share price
-0.84%
Change (1 day)
-83.80%
Change (1 year)

Cel-Sci (CVM) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : A$15.51 Million

According to Cel-Sci 's latest financial reports the company's total liabilities are A$15.51 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cel-Sci - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-09-30A$18.45 M-9.65%
2024-09-30A$20.42 M-24.17%
2023-09-30A$26.93 M-5.64%
2022-09-30A$28.54 M6.75%
2021-09-30A$26.73 M-7.91%
2020-09-30A$29.03 M-12.81%
2019-09-30A$33.3 M-18.69%
2018-09-30A$40.95 M22.35%
2017-09-30A$33.47 M0%
2016-09-30A$33.47 M-29.57%
2015-09-30A$47.52 M372.57%
2014-09-30A$10.05 M126.49%
2013-09-30A$4.44 M-49.14%
2012-09-30A$8.72 M-10.92%
2011-09-30A$9.79 M-5.02%
2010-09-30A$10.31 M-75.91%
2009-09-30A$42.82 M781.65%
2008-09-30A$4.85 M-28.33%
2007-09-30A$6.77 M-52.24%
2006-09-30A$14.18 M991.32%
2005-09-30A$1.3 M-33.03%
2004-09-30A$1.94 M-22.06%
2003-09-30A$2.49 M-50.02%
2002-09-30A$4.98 M382.73%
2001-09-30A$1.03 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
A$171.42 B 1,104,971.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$119.30 B 769,004.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$0.31 B 1,942.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
A$24.31 M 56.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$45.54 B 293,532.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
A$1.45 B 9,305.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$1.14 B 7,260.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$5.27 M-65.99%๐Ÿ‡บ๐Ÿ‡ธ USA